In vitro activity of human β-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 11, 2007, Pages 3853-3860

  Huang, Ling C ^a   Redfern, Rachel L ^a   Narayanan, Srihari ^a   Reins, Rose Y ^a   McDermott, Alison M ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; MUCIN 5AC;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CATION TRANSPORT; EPITHELIUM CELL; FILTRATION; HEAT INACTIVATION; HEATING; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; INNATE IMMUNITY; KERATITIS; LACRIMAL FLUID; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; SEPARATION TECHNIQUE;

ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOPRECIPITATION; MICROBIAL SENSITIVITY TESTS; MUCINS; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; SODIUM CHLORIDE; TEARS;

EID: 35848930094     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01317-06     Document Type: Article

References (72)

1. Aarbiou, J., R. M. Verhoosel, S. Van Wetering, W. I. De Boer, J. H. Van Krieken, S. V. Litvinov, K. F. Rabe, and P. S. Hiemstra. 2004. Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am. J. Respir. Cell Mol. Biol. 30:193-201.
2. Ahn, C. S., T. McMahon, J. Sugar, L. Zhou, and B. Y. Yue. 1999. Levels of alpha1-proteinase inhibitor and alpha2-macroglobulin in the tear film of patients with keratoconus. Cornea 18:194-198.
3. Akinbi, H. T., V. Narendran, A. K. Pass, P. Markart, and S. B. Hoath. 2004. Host defense proteins in vernix caseosa and amniotic fluid. Am. J. Obstet. Gynecol. 191:2090-2096.
4. Bals, R., X. Wang, Z. Wu, T. Freeman, V. Bafna, M. Zasloff, and J. M. Wilson. 1998. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Investig. 102:874-880.
5. Befus, A. D., C. Mowat, M. Gilchrist, J. Hu, S. Solomon, and A. Bateman. 1999. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J. Immunol. 163:947-953.
6. Belas, R., J. Manos, and R. Suvanasuthi. 2004. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 72:5159-5167.
7. Chaly, Y. V., E. M. Paleolog, T. S. Kolesnikova, I. I. Tikhonov, E. V. Petratchenko, and N. N. Voitenok. 2000. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur. Cytokine Netw. 11:257-266.
8. Chertov, O., D. F. Michiel, L. Xu, J. M. Wang, K. Tani, W. J. Murphy, D. L. Longo, D. D. Taub, and J. J. Oppenheim. 1996. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271:2935-2940.
9. Cole, A. M., S. Tahk, A. Oren, D. Yoshioka, Y. H. Kim, A. Park, and T. Ganz. 2001. Determinants of Staphylococcus aureus nasal carriage. Clin. Diagn. Lab. Immunol. 8:1064-1069.
10. Craig, J. P., P. A. Simmons, S. Patel, and A. Tomlinson. 1995. Refractive index and osmolality of human tears. Optom. Vis. Sci. 72:718-724.
11. de Leeuw, E., and W. Lu. 2007. Human defensins: turning defense into offense? Infect. Disord. Drug Targets 7:67-70.
12. Estrellas, P. S., Jr., L. G. Alionte, and J. A. Hobden. 2000. A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient. Curr. Eye Res. 20:157-165.
13. Felgentreff, K., C. Beisswenger, M. Griese, T. Gulder, G. Bringmann, and R. Bals. 2006. The antimicrobial peptide cathelicidin interacts with airway mucus. Peptides 27:3100-3106.
14. Fleiszig, S. M., M. S. Kwong, and D. J. Evans. 2003. Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid. Infect. Immun. 71:3866-3874.
15. Fung, K., C. Morris, and M. Duncan. 2002. Mass spectrometric techniques applied to the analysis of human tears: a focus on the peptide and protein constituents. Adv. Exp. Med. Biol. 506:601-605.
16. Gallo, R. L., M. Murakami, T. Ohtake, and M. Zaiou. 2002. Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunol. 110:823-831.
17. Ganz, T., and R. I. Lehrer. 1998. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10:41-44.
18. Ganz, T., and R. I. Lehrer. 1995. Defensins. Pharmacol. Ther. 66:191-205.
19. Ganz, T., M. E. Selsted, D. Szklarek, S. S. Harwig, K. Daher, D. F. Bainton, and R. I. Lehrer. 1985. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Investig. 76:1427-1435.
20. Gipson, I. K. 2004. Distribution of mucins at the ocular surface. Exp. Eye Res. 78:379-388.
21. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
22. Gordon, Y. J., L. C. Huang, E. G. Romanowski, K. A. Yates, R. J. Proske, and A. M. McDermott. 2005. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr. Eye Res. 30:385-394.
23. Gupta, A., T. Heigle, and S. C. Pflugfelder. 1997. Nasolacrimal stimulation of aqueous tear production. Cornea 16:645-648.
24. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.
25. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 1997. A peptide antibiotic from human skin. Nature 387:861.
26. Haynes, R. J., J. E. McElveen, H. S. Dua, P. J. Tighe, and J. Liversidge. 2000. Expression of human beta-defensins in intraocular tissues. Investig. Ophthalmol. Vis. Sci. 41:3026-3031.
27. Hobden, J. A., S. A. Masinick, R. P. Barrett, and L. D. Hazlett. 1995. Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection. Investig. Ophthalmol. Vis. Sci. 36:1107-1114.
28. Hoover, D. M., K. R. Rajashankar, R. Blumenthal, A. Puri, J. J. Oppenheim, O. Chertov, and J. Lubkowski. 2000. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 275:32911-32918.
29. Huang, L. C., D. Jean, and A. M. McDermott. 2005. Effect of preservative-free artificial tears on the antimicrobial activity of human beta-defensin-2 and cathelicidin LL-37 in vitro. Eye Contact Lens 31:34-38.
30. Huang, L. C., D. Jean, R. J. Proske, R. Y. Reins, and A. M. McDermott. 2007. Ocular surface expression and in vitro activity of antimicrobial peptides. Curr. Eye Res. 32:595-609.
31. Huang, L. C., T. D. Petkova, R. Y. Reins, R. J. Proske, and A. M. McDermott. 2006. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Investig. Ophthalmol. Vis. Sci. 47:2369-2380.
32. Jumblatt, M. M., R. W. McKenzie, and J. E. Jumblatt. 1999. MUC5AC mucin is a component of the human precorneal tear film. Investig. Ophthalmol. Vis. Sci. 40:43-49.
33. Mannis, M. J. 2002. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis. Trans. Am. Ophthalmol. Soc. 100:243-271.
34. McDermott, A. M., R. L. Redfern, and B. Zhang. 2001. Human β-defensin 2 is up-regulated during re-epithelialization of the cornea. Curr. Eye Res. 22:64-67.
35. McDermott, A. M., R. L. Redfern, B. Zhang, Y. Pei, L. Huang, and R. J. Proske. 2003. Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Investig. Ophthalmol. Vis. Sci. 44:1859-1865.
36. McDermott, A. M., D. Rich, J. Cullor, M. J. Mannis, W. Smith, T. Reid, and C. J. Murphy. 2006. The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears. Br. J. Ophthalmol. 90:609-611.
37. McNamara, N. A., R. Van, O. S. Tuchin, and S. M. Fleiszig. 1999. Ocular surface epithelia express mRNA for human beta defensin-2. Exp. Eye Res. 69:483-490.
38. Mookherjee, N., and R. E. Hancock. 2007. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life Sci. 64:922-933.
39. Morrison, G., F. Kilanowski, D. Davidson, and J. Dorin. 2002. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect. Immun. 70:3053-3060.
40. Moser, C., D. J. Weiner, E. Lysenko, R. Bals, J. N. Weiser, and J. M. Wilson. 2002. β-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70:3068-3072.
41. Murphy, C. J., B. A. Foster, M. J. Mannis, M. E. Selsted, and T. W. Reid. 1993. Defensins are mitogenic for epithelial cells and fibroblasts. J. Cell. Physiol. 155:408-413.
42. Nagaoka, I., S. Hirota, S. Yomogida, A. Ohwada, and M. Hirata. 2000. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49:73-79.
43. Narayanan, S., W. L. Miller, and A. M. McDermott. 2003. Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. Investig. Ophthalmol. Vis. Sci. 44:3795-3801.
44. Nishimura, M., Y. Abiko, Y. Kurashige, M. Takeshima, M. Yamazaki, K. Kusano, M. Saitoh, K. Nakashima, T. Inoue, and T. Kaku. 2004. Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. J. Dermatol. Sci. 36:87-95.
45. Niyonsaba, F., I. Nagaoka, and H. Ogawa. 2006. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit. Rev. Immunol. 26:545-576.
46. Niyonsaba, F., A. Someya, M. Hirata, H. Ogawa, and I. Nagaoka. 2001. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31:1066-1075.
47. O'Callaghan, R. J., L. S. Engel, J. A. Hobden, M. C. Callegan, L. C. Green, and J. M. Hill. 1996. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Investig. Ophthalmol. Vis. Sci. 37:534-543.
48. Oren, A., T. Ganz, L. Liu, and T. Meerloo. 2003. In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp. Mol. Pathol. 74:180-182.
49. Panyutich, A., and T. Ganz. 1991. Activated alpha 2-macroglobulin is a principal defensin-binding protein. Am. J. Respir. Cell Mol. Biol. 5:101-106.
50. Panyutich, A. V., P. S. Hiemstra, S. van Wetering, and T. Ganz. 1995. Human neutrophil defensin and serpins form complexes and inactivate each other. Am. J. Respir. Cell Mol. Biol 12:351-357.
51. Pillar, C. M., and J. A. Hobden. 2002. Pseudomonas aeruginosa exotoxin A and keratitis in mice. Investig. Ophthalmol. Vis. Sci. 43:1437-1444.
52. Redfern, R. L., R. J. Proske, and A. M. McDermott. 2004. Effect of defensins on corneal cell migration and cytokine production. Investig. Ophthalmol. Vis. Sci. 45:E-abstr. 4866.
53. Redl, B. 2000. Human tear lipocalin. Biochim. Biophys. Acta 1482:241-248.
54. Ruchaud-Sparagano, M. H., B. R. Westley, and F. E. May. 2004. The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa. Cell. Mol. Life Sci. 61:1946-1954.
55. Sakamoto, N., H. Mukae, T. Fujii, H. Ishii, S. Yoshioka, T. Kakugawa, K. Sugiyama, Y. Mizuta, J. Kadota, M. Nakazato, and S. Kohno. 2005. Differential effects of alpha- and beta-defensin on cytokine production by cultured human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L508-L513.
56. Salzman, N. H., D. Ghosh, K. M. Huttner, Y. Paterson, and C. L. Bevins. 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522-526.
57. Sathe, S., M. Sakata, A. R. Beaton, and R. A. Sack. 1998. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid. Curr. Eye Res. 17:348-362.
58. Schroder, J. M. 1999. Epithelial peptide antibiotics. Biochem. Pharmacol. 57:121-134.
59. Schroder, J. M., and J. Harder. 1999. Human beta-defensin-2. Int. J. Biochem. Cell Biol. 31:645-651.
60. Singh, P. K., H. P. Jia, K. Wiles, J. Hesselberth, L. Liu, B. A. Conway, E. P. Greenberg, E. V. Valore, M. J. Welsh, T. Ganz, B. F. Tack, and P. B. McCray, Jr. 1998. Production of beta-defensins by human airway epithelia. Proc. Natl. Acad. Sci. USA 95:14961-14966.
61. Singh, P. K., B. F. Tack, P. B. McCray, Jr., and M. J. Welsh. 2000. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L799-L805.
62. Taggart, C. C., C. M. Greene, S. G. Smith, R. L. Levine, P. B. McCray, Jr., S. O'Neill, and N. G. McElvaney. 2003. Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. J. Immunol. 171:931-937.
63. Territo, M. C., T. Ganz, M. E. Selsted, and R. Lehrer. 1989. Monocyte-chemotactic activity of defensins from human neutrophils. J. Clin. Investig. 84:2017-2020.
64. Tomita, T., S. Hitomi, T. Nagase, H. Matsui, T. Matsuse, S. Kimura, and Y. Ouchi. 2000. Effect of ions on antibacterial activity of human beta defensin 2. Microbiol. Immunol. 44:749-754.
65. Valore, E. V., C. H. Park, A. J. Quayle, K. R. Wiles, P. B. McCray, Jr., and T. Ganz. 1998. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Investig. 101:1633-1642.
66. Van Haeringen, N. J. 1981. Clinical biochemistry of tears. Surv. Ophthalmol. 26:84-96.
67. Van Wetering, S., S. P. Mannesse-Lazeroms, M. A. Van Sterkenburg, M. R. Daha, J. H. Dijkman, and P. S. Hiemstra. 1997. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am. J. Physiol. 272:L888-L896.
68. White, S. H., W. C. Wimley, and M. E. Selsted. 1995. Structure, function, and membrane integration of defensins. Curr. Opin. Struct. Biol. 5:521-527.
69. Wilson, C. L., A. J. Ouellette, D. P. Satchell, T. Ayabe, Y. S. Lopez-Boado, J. L. Stratman, S. J. Hultgren, L. M. Matrisian, and W. C. Parks. 1999. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286:113-117.
70. Yang, D., O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schroder, J. M. Wang, O. M. Howard, and J. J. Oppenheim. 1999. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528.
71. Zasloff, M. 1992. Antibiotic peptides as mediators of innate immunity. Curr. Opin. Immunol. 4:3-7.
72. Zhou, L., L. Q. Huang, R. W. Beuerman, M. E. Grigg, S. F. Li, F. T. Chew, L. Ang, M. E. Stern, and D. Tan. 2004. Proteomic analysis of human tears: defensin expression after ocular surface surgery. J. Proteome Res. 3:410-416.